PROJECT SUMMARY: The synthesis of biologically active molecules through selective C–C bond-forming reactions is central to the discovery of new therapeutics. Though forging C–C bonds is often more challenging at C(sp3)-centers than C(sp2)-centers, especially when new stereocenters emerge, clinical success is correlated with sp3-richness. Consequently, developing new methods to rapidly generate complex, sp3-rich compounds from simple starting materials presents an opportunity for synthetic innovation to accelerate the discovery of new medicines. Nature constructs bioactive molecules using enzymes to form C(sp3)–C(sp3) bonds stereoselectively, and some of these enzymes have been harnessed for pharmaceutical synthesis. However, Nature offers many synthetically useful enzymes that have not been explored for use in biocatalysis. Here, hydroalkylase enzymes will be developed for synthetic applications to form new intermolecular C(sp3)–C(sp3) bonds from simple, achiral starting materials. Enzymatic hydroalkylation can directly activate C–H bonds without pre-functionalization and has the potential to form up to three contiguous stereocenters in one step. Glycyl radical enzyme (GRE) hydroalkylases can convert C(sp3)–H bonds directly into new C–C bonds using simple amino acid-based radicals. The potential to use GRE hydroalkylases for biocatalysis has been noted for decades, but an inability to install the amino acid-based radicals in vitro severely limited their application. Recently, a platform to overcome this limitation was developed, enabling the generation of amino acid-based radicals within purified enzyme. Theme 1 of this proposal builds on this advance to investigate the native substrate scopes of two GRE hydroalkylases: one that functionalizes toluene and one that functionalizes n-hexadecane. These two wild-type enzymes will be used as starting points to engineer variants through genetic manipulation to broaden substrate scope, enhance selectivity, and discover non-